TSE:SVA Sernova (SVA) Stock Price, News & Analysis → The Small Biotech with a BIG Cancer Solution (From Behind the Markets) (Ad) Free SVA Stock Alerts C$0.56 +0.01 (+1.82%) (As of 03/27/2024 ET) Add Compare Share Share Today's RangeC$0.54▼C$0.5750-Day RangeC$0.54▼C$0.7052-Week RangeC$0.51▼C$1.15Volume85,630 shsAverage Volume137,339 shsMarket CapitalizationC$169.86 millionP/E RatioN/ADividend Yield7.86%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsHeadlinesStock AnalysisChartCompetitorsEarningsHeadlines Get Sernova alerts: Email Address Ad DTImy top trade on these 9 tickersThis indicator is uniquely designed to spot the most significant moves in the top stocks out there (and according to our backtesting it has historically nailed these moves with a stunning 90% accuracy). Now, most folks have been saying NVDA is way overbought or overpriced. They didn’t want to “buy at the top” 6 weeks ago… Or again 4 weeks ago… or again 2 weeks ago… And it’s not their fault! That’s what all the talking heads were saying too. But the Apex Indicator would have clearly shown that these were opportunities to buy. And, sure enough, Nvidia slammed through the recommended targets again and again.Click Here for this Powerful Workshop About Sernova Stock (TSE:SVA)Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.Read More SVA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SVA Stock News HeadlinesMarch 23, 2024 | americanbankingnews.comSernova Corp. (TSE:SVA) to Post Q3 2024 Earnings of ($0.04) Per Share, Echelon Wealth Partners ForecastsMarch 14, 2024 | theglobeandmail.comNYC Arts Organization, Autumn Salon, Announces Next Concert 'Music Box'March 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…February 20, 2024 | finance.yahoo.comSernova Corp (PSH.MU)February 17, 2024 | morningstar.comSernova Corp SVAJanuary 9, 2024 | finance.yahoo.comWe Think Sernova (TSE:SVA) Can Afford To Drive Business GrowthNovember 27, 2023 | markets.businessinsider.comSernova Gets FDA Orphan Drug, Rare Pediatric Disease Designations For Hemophilia A ProgramNovember 27, 2023 | finance.yahoo.comSernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDAMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.October 11, 2023 | finance.yahoo.comSernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA CongressOctober 4, 2023 | markets.businessinsider.comH.C. Wainwright Thinks Sernova’s Stock is Going to RecoverSeptember 29, 2023 | markets.businessinsider.comH.C. Wainwright Reaffirms Their Buy Rating on Sernova (SVA)September 14, 2023 | markets.businessinsider.comSernova (SVA) Gets a Buy Rating from Echelon Wealth PartnersSeptember 14, 2023 | finance.yahoo.comSernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22September 13, 2023 | finance.yahoo.comSernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business UpdateSeptember 5, 2023 | markets.businessinsider.comEchelon Wealth Partners Maintains Their Buy Rating on Sernova (SVA)August 4, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Wednesday (SVA)August 2, 2023 | finance.yahoo.comIs Sernova (TSE:SVA) In A Good Position To Invest In Growth?July 26, 2023 | finance.yahoo.comSernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business OfficerMay 3, 2023 | marketwatch.comEQS-News: Sernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell ApplicationsMay 3, 2023 | finance.yahoo.comSernova Announces Research Collaboration with AstraZeneca to Evaluate Novel Potential Therapeutic Cell ApplicationsApril 29, 2023 | theglobeandmail.comClosing Bell: Sernova Corp up on Friday (SVA)April 21, 2023 | theglobeandmail.comClosing Bell: Sernova Corp flat on Friday (SVA)April 19, 2023 | theglobeandmail.comClosing Bell: Sernova Corp down on Tuesday (SVA)April 18, 2023 | theglobeandmail.comClosing Bell: Sernova Corp up on Monday (SVA)April 17, 2023 | finance.yahoo.comConcerned Shareholders of Sernova Corp. Stand by their StatementsApril 15, 2023 | theglobeandmail.comClosing Bell: Sernova Corp down on Friday (SVA)See More Headlines Receive SVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/18/2024Today3/28/2024Next Earnings (Estimated)6/11/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:SVA CUSIPN/A CIKN/A Webwww.sinovacbio.com Phone861082890088FaxN/AEmployees1,959Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-39,000,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-129.73% Return on Assets-67.87% Debt Debt-to-Equity Ratio1.09 Current Ratio2.19 Quick Ratio18.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.09 per share Price / Cash Flow6.15 Book ValueC$0.04 per share Price / Book14.00Miscellaneous Outstanding Shares303,330,000Free FloatN/AMarket CapC$169.86 million OptionableNot Optionable Beta1.60 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Philip M. Toleikis B.A.M.Sc., Ph.D., President, CTO, Director of Technology & DirectorMr. David Swetlow C.AC.A., CPA, Chief Financial OfficerMr. Christopher BarnesVice President of Investor RelationsDr. Frank Shannon M.D.Vice President of Clinical Development & Regulatory AffairsMs. Cynthia PussinenCEO & DirectorMr. Douglas MaretChief Science OfficerDr. Modestus Obochi M.B.A.Ph.D., Chief Business OfficerMore ExecutivesKey CompetitorsBriaCell TherapeuticsCVE:BCTImmunoPrecise AntibodiesCVE:IPAMedicenna TherapeuticsTSE:MDNAOncolytics BiotechTSE:ONCScythian BiosciencesCVE:SCYBView All Competitors SVA Stock Analysis - Frequently Asked Questions How have SVA shares performed in 2024? Sernova's stock was trading at C$0.70 at the beginning of 2024. Since then, SVA stock has decreased by 20.0% and is now trading at C$0.56. View the best growth stocks for 2024 here. When is Sernova's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024. View our SVA earnings forecast. How were Sernova's earnings last quarter? Sernova Corp. (TSE:SVA) issued its quarterly earnings data on Monday, March, 18th. The company reported ($0.03) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.03). How do I buy shares of Sernova? Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:SVA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.